|
1
|
Cao Q, Guo Z, Du S, Ling H and Song C:
Circular RNAs in the pathogenesis of atherosclerosis. Life Sci.
255(117837)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kattoor AJ, Goel A and Mehta JL: LOX-1:
Regulation, signaling and its role in atherosclerosis. Antioxidants
(Basel). 8(218)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cheng YC, Sheen JM, Hu WL and Hung YC:
Polyphenols and oxidative stress in atherosclerosis-related
ischemic heart disease and stroke. Oxid Med Cell Longev.
2017(8526438)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lu QB, Wan MY, Wang PY, Zhang CX, Xu DY,
Liao X and Sun HJ: Chicoric acid prevents PDGF-BB-induced VSMC
dedifferentiation, proliferation and migration by suppressing
ROS/NF-κB/mTOR/P70S6K signaling cascade. Redox Biol. 14:656–668.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ito S, Yokoyama U, Nakakoji T, Cooley MA,
Sasaki T, Hatano S, Kato Y, Saito J, Nicho N, Iwasaki S, et al:
Fibulin-1 integrates subendothelial extracellular matrices and
contributes to anatomical closure of the ductus arteriosus.
Arterioscler Thromb Vasc Biol. 40:2212–2226. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu BF, Liu R, Huang CX, He BS, Li GY, Sun
HS, Feng ZP and Bao MH: Identification of key genes in ruptured
atherosclerotic plaques by weighted gene correlation network
analysis. Sci Rep. 10(10847)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gao JB, Lin L, Men XQ, Zhao JB, Zhang MH,
Jin LP, Gao SJ, Zhao SQ and Dong JT: Fibulin-5 protects the
extracellular matrix of chondrocytes by inhibiting the
Wnt/β-catenin signaling pathway and relieves osteoarthritis. Eur
Rev Med Pharmacol Sci. 24:5249–5258. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Meliala ITS, Hosea R, Kasim V and Wu S:
The biological implications of Yin Yang 1 in the hallmarks of
cancer. Theranostics. 10:4183–4200. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu H, Schmidt-Supprian M and Shi Y,
Hobeika E, Barteneva N, Jumaa H, Pelanda R, Reth M, Skok J,
Rajewsky K and Shi Y: Yin Yang 1 is a critical regulator of B-cell
development. Genes Dev. 21:1179–1189. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Blättler SM, Cunningham JT, Verdeguer F,
Chim H, Haas W, Liu H, Romanino K, Rüegg MA, Gygi SP, Shi Y and
Puigserver P: Yin Yang 1 deficiency in skeletal muscle protects
against rapamycin-induced diabetic-like symptoms through activation
of insulin/IGF signaling. Cell Metab. 15:505–517. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sui G, Affar el B and Shi Y, Brignone C,
Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR and Shi Y:
Yin Yang 1 is a negative regulator of p53. Cell. 117:859–872.
2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yue Y, Lv W, Zhang L and Kang W: miR-147b
influences vascular smooth muscle cell proliferation and migration
via targeting YY1 and modulating Wnt/β-catenin activities. Acta
Biochim Biophys Sin (Shanghai). 50:905–913. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tian FJ, An LN, Wang GK, Zhu JQ, Li Q,
Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, et al: Elevated
microRNA-155 promotes foam cell formation by targeting HBP1 in
atherogenesis. Cardiovasc Res. 103:100–110. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Grootaert MOJ, Moulis M, Roth L, Martinet
W, Vindis C, Bennett MR and De Meyer GRY: Vascular smooth muscle
cell death, autophagy and senescence in atherosclerosis. Cardiovasc
Res. 114:622–634. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kavurma MM and Khachigian LM: Sp1 inhibits
proliferation and induces apoptosis in vascular smooth muscle cells
by repressing p21WAF1/Cip1 transcription and cyclin
D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem.
278:32537–32543. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nasiri-Ansari Ν, Dimitriadis GK,
Agrogiannis G, Perrea D, Kostakis ID, Kaltsas G, Papavassiliou AG,
Randeva HS and Kassi E: Canagliflozin attenuates the progression of
atherosclerosis and inflammation process in APOE knockout mice.
Cardiovasc Diabetol. 17(106)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Terzuoli E, Nannelli G, Giachetti A,
Morbidelli L, Ziche M and Donnini S: Targeting
endothelial-to-mesenchymal transition: The protective role of
hydroxytyrosol sulfate metabolite. Eur J Nutr. 59:517–527.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Viedma-Rodríguez R, Martínez-Hernández MG,
Martínez-Torres DI and Baiza-Gutman LA: Epithelial mesenchymal
transition and progression of breast cancer promoted by diabetes
mellitus in mice are associated with increased expression of
glycolytic and proteolytic enzymes. Horm Cancer. 11:170–181.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Paapstel K, Zilmer M, Eha J, Tootsi K,
Piir A and Kals J: Association between Fibulin-1 and aortic
augmentation index in male patients with peripheral arterial
disease. Eur J Vasc Endovasc Surg. 51:76–82. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nguyen AD, Itoh S, Jeney V, Yanagisawa H,
Fujimoto M, Ushio-Fukai M and Fukai T: Fibulin-5 is a novel binding
protein for extracellular superoxide dismutase. Circ Res.
95:1067–1074. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Orriols M, Varona S, Martí-Pàmies I, Galán
M, Guadall A, Escudero JR, Martín-Ventura JL, Camacho M, Vila L,
Martínez-González J and Rodríguez C: Down-regulation of Fibulin-5
is associated with aortic dilation: role of inflammation and
epigenetics. Cardiovasc Res. 110:431–442. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sarvagalla S, Kolapalli SP and
Vallabhapurapu S: The two sides of YY1 in cancer: A friend and a
foe. Front Oncol. 9(1230)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Makhlouf M, Ouimette JF, Oldfield A,
Navarro P, Neuillet D and Rougeulle C: A prominent and conserved
role for YY1 in Xist transcriptional activation. Nat Commun.
5(4878)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cai Y, Jin J, Yao T, Gottschalk AJ,
Swanson SK, Wu S, Shi Y, Washburn MP, Florens L, Conaway RC and
Conaway JW: YY1 functions with INO80 to activate transcription. Nat
Struct Mol Biol. 14:872–874. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Wei SY, Shih YT, Wu HY, Wang WL, Lee PL,
Lee CI, Lin CY, Chen YJ, Chien S and Chiu JJ: Endothelial Yin Yang
1 phosphorylation at S118 induces atherosclerosis under flow. Circ
Res. 129:1158–1174. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jian D, Dai B, Hu X, Yao Q, Zheng C and
Zhu J: ox-LDL increases microRNA-29a transcription through
upregulating YY1 and STAT1 in macrophages. Cell Biol Int.
41:1001–1011. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Guo J, Xiang Q, Xin Y, Huang Y, Zou G and
Liu T: miR-544 promotes maturity and antioxidation of stem
cell-derived endothelial like cells by regulating the YY1/TET2
signalling axis. Cell Commun Signal. 18(35)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Qin L, Yang YB, Yang YX, Gong YZ, Li XL,
Li GY, Luo HD, Xie XJ, Zheng XL and Liao DF: Inhibition of smooth
muscle cell proliferation by ezetimibe via the cyclin D1-MAPK
pathway. J Pharmacol Sci. 125:283–291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vadiveloo PK, Filonzi EL, Stanton HR and
Hamilton JA: G1 phase arrest of human smooth muscle cells by
heparin, IL-4 and cAMP is linked to repression of cyclin D1 and
cdk2. Atherosclerosis. 133:61–69. 1997.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang Y, Li YH, Liu C, Nie CJ, Zhang XH,
Zheng CY, Jiang W, Yin WN, Ren MH, Jin YX, Liu SF, et al: miR-29a
regulates vascular neointimal hyperplasia by targeting YY1. Cell
Prolif. 50(e12322)2017.PubMed/NCBI View Article : Google Scholar
|
